Objectives This study aimed to assess the potential role of 3-dimensional (3D) fractal dimension (FD) derived from contrast-enhanced CT images in predicting microvascular invasion (MVI) in patients with hepatocellular carcinoma (HCC). Materials and methods This retrospective study included 655 patients with surgically confirmed HCC from two medical centers (training set: 406 patients; internal test set: 170 patients; external test set: 79 patients). Box-counting algorithms were used to compute 3D FD values from portal venous phase images. Univariable and multivariable logistic regression analyses identified independent predictors. The model’s area under the curve (AUC) was calculated. Recurrence-free survival (RFS) and overall survival (OS) were evaluated using the Kaplan–Meier method. Results Patients with MVI-positive HCC demonstrated significantly higher FD values compared to those with MVI-negative HCC (p < 0.01). The FD achieved AUCs of 0.786 (95% CI: 0.713–0.849) in the internal test set and 0.776 (95% CI: 0.669–0.874) in the external test set. A combined model incorporating alpha-fetoprotein, tumor size, tumor number, and FD showed superior diagnostic performance for MVI prediction compared to the clinical model, with AUCs of 0.795 (95% CI: 0.720–0.860) vs 0.752 (95% CI: 0.670–0.825) in the internal test set, and 0.826 (95% CI: 0.721–0.915) vs 0.739 (95% CI: 0.613–0.849) in the external test set. Patients stratified as high-risk MVI exhibited significantly worse RFS and OS outcomes compared to low-risk MVI patients (p < 0.05). Conclusion The 3D FD values differed significantly between MVI-positive and MVI-negative HCC patients. Integrating FD into the clinical model enhanced MVI prediction accuracy and may help identify patients at high risk. Key Points <Emphasis Type="BoldItalic">Question</Emphasis> The predictive value of three-dimensional (3D) fractal dimension (FD) derived from contrast-enhanced CT images for identifying MVI-positive HCC remains unclear. <Emphasis Type="BoldItalic">Findings</Emphasis> Quantitative indicators derived from fractal analysis were able to predict MVI. The developed model demonstrated improved performance when incorporating fractal dimension. <Emphasis Type="BoldItalic">Clinical relevance</Emphasis> Fractal analysis based on contrast-enhanced CT is a feasible approach for evaluating MVI and provides additional clinical value for prognostic assessment. It may serve as a reference for preoperative MVI estimation and assist clinicians in executing more tailored therapies. Graphical Abstract

3D fractal dimension analysis of CT imaging for microvascular invasion prediction in hepatocellular carcinoma

期刊论文
出版模式：

开放获取
发表日期：

2025年8月7日

查看全文

Feng Che,
Qian Li,
Wei Ren,
Hehan Tang,
Guli Zaina,
Shan Yao,
Ning Zhang,
Shaocheng Zhu,
Bin Song,
Yi Wei

摘要

Objectives

This study aimed to assess the potential role of 3-dimensional (3D) fractal dimension (FD) derived from contrast-enhanced CT images in predicting microvascular invasion (MVI) in patients with hepatocellular carcinoma (HCC).

Materials and methods

This retrospective study included 655 patients with surgically confirmed HCC from two medical centers (training set: 406 patients; internal test set: 170 patients; external test set: 79 patients). Box-counting algorithms were used to compute 3D FD values from portal venous phase images. Univariable and multivariable logistic regression analyses identified independent predictors. The model’s area under the curve (AUC) was calculated. Recurrence-free survival (RFS) and overall survival (OS) were evaluated using the Kaplan–Meier method.

Results

Patients with MVI-positive HCC demonstrated significantly higher FD values compared to those with MVI-negative HCC (p < 0.01). The FD achieved AUCs of 0.786 (95% CI: 0.713–0.849) in the internal test set and 0.776 (95% CI: 0.669–0.874) in the external test set. A combined model incorporating alpha-fetoprotein, tumor size, tumor number, and FD showed superior diagnostic performance for MVI prediction compared to the clinical model, with AUCs of 0.795 (95% CI: 0.720–0.860) vs 0.752 (95% CI: 0.670–0.825) in the internal test set, and 0.826 (95% CI: 0.721–0.915) vs 0.739 (95% CI: 0.613–0.849) in the external test set. Patients stratified as high-risk MVI exhibited significantly worse RFS and OS outcomes compared to low-risk MVI patients (p < 0.05).

Conclusion

The 3D FD values differed significantly between MVI-positive and MVI-negative HCC patients. Integrating FD into the clinical model enhanced MVI prediction accuracy and may help identify patients at high risk.

Key Points

Question The predictive value of three-dimensional (3D) fractal dimension (FD) derived from contrast-enhanced CT images for identifying MVI-positive HCC remains unclear.

Findings Quantitative indicators derived from fractal analysis were able to predict MVI. The developed model demonstrated improved performance when incorporating fractal dimension.

Clinical relevance Fractal analysis based on contrast-enhanced CT is a feasible approach for evaluating MVI and provides additional clinical value for prognostic assessment. It may serve as a reference for preoperative MVI estimation and assist clinicians in executing more tailored therapies.

Graphical Abstract